Sequence design and practical implementation of antisense oligonucleotides in neuroendocrinology.
Neumann
I D
ID
Max Planck Institute of Psychiatry, Munich, Germany.
Toschi
N
N
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000235:genetics; D015195:Drug Design; D009452:Neuroendocrinology / Q000295:instrumentation / Q000379:methods*; D009479:Neuropeptides / Q000235:genetics*; D009690:Nucleic Acid Conformation; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology*; D010121:Oxytocin / Q000235:genetics; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects; D012333:RNA, Messenger / Q000187:drug effects*; D051381:Rats; D018013:Receptors, Neuropeptide / Q000187:drug effects / Q000235:genetics; D013495:Supraoptic Nucleus / Q000187:drug effects; D014667:Vasopressins / Q000235:genetics
D009479:Neuropeptides; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D018013:Receptors, Neuropeptide; D014667:Vasopressins; D010121:Oxytocin; D003346:Corticotropin-Releasing Hormone